APA (7th ed.) Citation

Martín, I., Navarro, B., Serrano, A., Villamón, E., Calabuig, M., Solano, C., . . . Tormo, M. (2020). Impact of clinical features, cytogenetics, genetic mutations, and methylation dynamics of CDKN2B and DLC-1 promoters on treatment response to azacitidine. Annals of hematology, 99(3), 527-537. https://doi.org/10.1007/s00277-020-03932-8

Chicago Style (17th ed.) Citation

Martín, Iván, et al. "Impact of Clinical Features, Cytogenetics, Genetic Mutations, and Methylation Dynamics of CDKN2B and DLC-1 Promoters on Treatment Response to Azacitidine." Annals of Hematology 99, no. 3 (2020): 527-537. https://doi.org/10.1007/s00277-020-03932-8.

MLA (9th ed.) Citation

Martín, Iván, et al. "Impact of Clinical Features, Cytogenetics, Genetic Mutations, and Methylation Dynamics of CDKN2B and DLC-1 Promoters on Treatment Response to Azacitidine." Annals of Hematology, vol. 99, no. 3, 2020, pp. 527-537, https://doi.org/10.1007/s00277-020-03932-8.